EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A carbapenem-focused antimicrobial stewardship programme implemented during the COVID-19 pandemic in a setting of high endemicity for multidrug-resistant Gram-negative bacteria

Nikolaos Spernovasilis iD, Evangelos I Kritsotakis iD, Anna Mathioudaki, Alexandra Vouidaski, Christos Spanias, Maria Petrodaskalaki, Petros Ioannou, Georgios Chamilos, Diamantis P Kofteridis

Journal of Antimicrobial Chemotherapy · 2023

DOI: 10.1093/jac/dkad035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2023. Verfasst von Nikolaos Spernovasilis und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Crete, Heraklion, Greece. Hauptthemen laut MEDLINE: Gram-Negative Bacterial Infections, Antimicrobial Stewardship, COVID-19. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Background Greece is among the countries characterized by high rates of antimicrobial resistance and high consumption of antibiotics, including carbapenems.

Objectives

To measure the impact of a carbapenem-focused antimicrobial stewardship programme (ASP) on the antibiotic consumption and patient outcomes in a Greek tertiary hospital during the COVID-19 pandemic.

Methods

A quasi-experimental, before–after study, comparing a 12 month pre-intervention period with a 12 month intervention period in which a carbapenem-focused ASP was implemented.

Results

A total of 1268 patients were enrolled. The proportion of admitted patients who received carbapenems decreased from 4.1% (842 of 20 629) to 2.3% (426 of 18 245) (−1.8%; P < 0.001). A decrease of −4.9 DDD/100 patient-days (PD) (95% CI −7.3 to −2.6; P = 0.007) in carbapenem use and an increase in the use of piperacillin/tazobactam [+2.1 DDD/100 PD (95% CI 1.0–3.3; P = 0.010)] were observed. Thirty-day mortality following initiation of carbapenem treatment and all-cause in-hospital mortality remained unaltered after ASP implementation. In contrast, length of hospital stay increased (median 17.0 versus 19.0 days; P < 0.001), while the risk of infection-related readmission within 30 days of hospital discharge decreased (24.6% versus 16.8%; P = 0.007). In the post-implementation period, acceptance of the ASP intervention was associated with lower daily hazard of in-hospital death [cause-specific HR (csHR) 0.49; 95% CI 0.30–0.80], lower odds of 30 day mortality (OR 0.36; 95% CI 0.18–0.70) and higher rate of treatment success (csHR 2.45; 95% CI 1.59–3.77).

Conclusions

Implementing and maintaining a carbapenem-focused ASP is feasible, effective and safe in settings with high rates of antimicrobial resistance, even during the COVID-19 pandemic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gram-Negative Bacterial InfectionsAntimicrobial StewardshipCOVID-19HumansCarbapenemsHospital MortalityPandemicsAnti-Bacterial AgentsGram-Negative Bacteria

Substanzen

CarbapenemsAnti-Bacterial Agents

Autor:innen und Institutionen

  • School of Medicine, University of Crete, Heraklion, Greece.
  • Department of Internal Medicine and Infectious Diseases, University Hospital of Heraklion, Heraklion, Greece.
  • Laboratory of Biostatistics, School of Medicine, University of Crete, Heraklion, Greece.
  • Department of Pharmacy, University Hospital of Heraklion, Heraklion, Greece.
  • Department of Quality & Research, University Hospital of Heraklion, Heraklion, Greece.
  • Department of Clinical Microbiology, University Hospital of Heraklion, Heraklion, Greece.

ORCID-Profile: Nikolaos Spernovasilis, Evangelos I Kritsotakis

Zitieren

APA

Spernovasilis, N., Kritsotakis, E. I., Mathioudaki, A., Vouidaski, A., Spanias, C., Petrodaskalaki, M., Ioannou, P., Chamilos, G., & Kofteridis, D. P. (2023). A carbapenem-focused antimicrobial stewardship programme implemented during the COVID-19 pandemic in a setting of high endemicity for multidrug-resistant Gram-negative bacteria. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkad035

Vancouver

Spernovasilis N, Kritsotakis EI, Mathioudaki A, Vouidaski A, Spanias C, Petrodaskalaki M, et al. A carbapenem-focused antimicrobial stewardship programme implemented during the COVID-19 pandemic in a setting of high endemicity for multidrug-resistant Gram-negative bacteria. Journal of Antimicrobial Chemotherapy. 2023. doi:10.1093/jac/dkad035

BibTeX
@article{Spernovasilis2023,
  author = {Spernovasilis, Nikolaos and Kritsotakis, Evangelos I and Mathioudaki, Anna and Vouidaski, Alexandra and Spanias, Christos and Petrodaskalaki, Maria and Ioannou, Petros and Chamilos, Georgios and Kofteridis, Diamantis P},
  title = {A carbapenem-focused antimicrobial stewardship programme implemented during the COVID-19 pandemic in a setting of high endemicity for multidrug-resistant Gram-negative bacteria},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2023},
  doi = {10.1093/jac/dkad035}
}
Kostenlos starten →